The addition of dexamethasone to dolasetron or haloperidol for treatment of established postoperative nausea and vomiting

Anaesthesia

Volumn 62, Issue 8, 2007, Pages 810-817

  Rusch D ^a   Arndt, C ^a   Martin, H ^a   Kranke, P ^b  

^a UNIVERSITY HOSPITAL MARBURG   (Germany)

^b UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIEMETIC AGENT; CORTICOSTEROID; DEXAMETHASONE; DOLASETRON MESILATE; HALOPERIDOL; INHALATION ANESTHETIC AGENT; NITROUS OXIDE; OPIATE; PIRITRAMIDE; PLACEBO; SEROTONIN 3 ANTAGONIST; TRAMADOL;

ADULT; AGED; ANOREXIA; ARTICLE; BACKACHE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIZZINESS; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG POTENTIATION; FEMALE; FLATULENCE; GENERAL ANESTHESIA; GENERAL SURGERY; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MYALGIA; ORTHOPEDIC SURGERY; PATIENT MONITORING; POSTOPERATIVE NAUSEA AND VOMITING; RANDOMIZED CONTROLLED TRIAL; RESTLESSNESS; SHIVERING; SIDE EFFECT; SLEEP DISORDER; SORE THROAT; SWEATING; XEROSTOMIA;

ADOLESCENT; ADULT; AGED; ANTIEMETICS; DEXAMETHASONE; DRUG THERAPY, COMBINATION; FEMALE; HALOPERIDOL; HUMANS; INDOLES; MALE; MIDDLE AGED; POSTOPERATIVE NAUSEA AND VOMITING; QUINOLIZINES; RISK FACTORS; SEROTONIN ANTAGONISTS; TREATMENT OUTCOME;

EID: 34547114500     PISSN: 00032409     EISSN: 13652044     Source Type: Journal    
DOI: 10.1111/j.1365-2044.2007.05136.x     Document Type: Article

References (19)

1. Gan TJ, Meyer T, Apfel CC, et al. Consensus guidelines for managing postoperative nausea and vomiting. Anesthesia and Analgesia 2003; 97: 62-71.
2. Habib AS, Gan TJ. Evidence-based management of postoperative nausea and vomiting: A review. Canadian Journal of Anaesthesia 2004; 51: 326-341.
3. Kazemi-Kjellberg F, Henzi I, Tramer MR. Treatment of established postoperative nausea and vomiting: A quantitative systematic review. BioMed Central Anesthesiology 2001; 1: 2.
4. Apfel CC, Korttila K, Abdalla M, et al. A factorial trial of six interventions for the prevention of postoperative nausea and vomiting. New England Journal of Medicine 2004; 350: 2441-2451.
5. Henzi I, Sonderegger J, Tramer MR. Efficacy, dose-response, and adverse effects of droperidol for prevention of postoperative nausea and vomiting. Canadian Journal of Anaesthesia 2000; 47: 537-551.
6. Eberhart LH, Morin AM, Georgieff M. [Dexamethasone for prophylaxis of postoperative nausea and vomiting. A meta-analysis of randomized controlled studies] Anaesthesist 2000; 49: 713-720.
7. Henzi I, Walder B, Tramer MR. Dexamethasone for the prevention of postoperative nausea and vomiting: A quantitative systematic review. Anesthesia and Analgesia 2000; 90: 186-194.
8. Gan TJ, White PF, Scuderi PE, Watcha MF, Kovac A. FDA 'black box' warning regarding use of droperidol for postoperative nausea and vomiting: Is it justified? Anesthesiology 2002; 97: 287.
9. Apfel CC, Laara E, Koivuranta M, Greim CA, Roewer N. A simplified risk score for predicting postoperative nausea and vomiting: Conclusions from cross-validations between two centers. Anesthesiology 1999; 91: 693-700.
10. Apfel CC, Korttila K, Abdalla M, et al. An international multi-center protocol to assess the single and combined benefits of antiemetic interventions in a controlled clinical trial of a 2x2x2x2x2x2 factorial design (IMPACT). Controlled Clinical Trials 2003; 24: 736-751.
11. Korttila K, Apfel CC. Factorial design provides evidence to guide practice of anaesthesia. Acta Anaesthesiologica Scandinavica 2005; 49: 927-929.
12. Macario A, Claybon L, Pergolizzi JV. Anesthesiologists' practice patterns for treatment of postoperative nausea and vomiting in the ambulatory Post Anesthesia Care Unit. BioMed Central Anesthesiology 2006; 6: 6.
13. Eberhart LH, Frank S, Lange H, et al. Systematic review on the recurrence of postoperative nausea and vomiting after a first episode in the recovery room -implications for the treatment of PONV and related clinical trials. BioMed Central Anesthesiology 2006; 6: 14.
14. Suzuki T, Sugimoto M, Koyama H, Mashimo T, Uchida I. Inhibitory effect of glucocorticoids on human-cloned 5-hydroxytryptamine3A receptor expressed in xenopus oocytes. Anesthesiology 2004; 101: 660-665.
15. Buttner M, Walder B, von Elm E, Tramer MR. Is low-dose haloperidol a useful antiemetic? A meta-analysis of published and unpublished randomized trials. Anesthesiology 2004; 101: 1454-1463.
16. Habib AS, Gan TJ. The effectiveness of rescue antiemetics after failure of prophylaxis with ondansetron or droperidol: A preliminary report. Journal of Clinical Anesthesia 2005; 17: 62-65.
17. Kovac AL, O'Connor TA, Pearman MH, et al. Efficacy of repeat intravenous dosing of ondansetron in controlling postoperative nausea and vomiting: a randomized, double-blind, placebo-controlled multicenter trial. Journal of Clinical Anesthesia 1999; 11: 453-459.
18. Aspinall RL, Goodman NW. Denial of effective treatment and poor quality of clinical information in placebo controlled trials of ondansetron for postoperative nausea and vomiting: A review of published trials. British Medical Journal 1995; 311: 844-846.
19. Adams AK. Use of placebo in studies of postoperative nausea and vomiting is unethical. British Medical Journal 1996; 313: 233.